(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Tofacitinib Citrate Impurity is derived from (3R,?4R)?-N,?4-?Dimethyl-?1-?benzyl?-3-?piperidinamine (D464895), which is a reagent used in the preparation of Janus tyrosine kinase inhibitors for the treatment of autoimmune diseases.

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14336	58
career henan chemical co	+86-0371-86658258 15093356674;	factory@coreychem.com	China	29826	58
ANHUI WITOP BIOTECH CO., LTD	+8615255079626	eric@witopchemical.com	China	23556	58
AFINE CHEMICALS LIMITED	0571-85134551	info@afinechem.com	CHINA	15377	58
CR Corporation Lomited		fred.wen@crcorporation.cn	CHINA	12069	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11927	58
LEAPCHEM CO., LTD.	+86-852-30606658	market18@leapchem.com	China	43348	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	+8613627253706	sale@hdimpurity.com	China	1490	58
Zhuhai Yourun Co., Ltd.	0756-6811852 13923369215	zhuhaiyourun@126.com	China	128	55
Jiangsu Vcare PharmaTech Co., Ltd.	025-58741518; 18013018875	sales@vcarepharmatech.com	China	308	61

1640971-60-3()Verwandte Suche:

---

• ofacitinib iMpurity
• Tofacitinib Citrate Impurity
• Tofacitinib Impurity 11
• Tofacitinib Impurity 14
• Tofacitinib Impurity 15
• Tofacitinib Impurity 18
• Tofacitinib Impurity 9
• 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl) (methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate-one
• Tofacitinib Impurity TBA
• Tofacitinib Impurity 5 DiHCl
• N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
• PF-05579970
• 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
• Tofaimpurity iMpurity
• Tofacitinib Related Compound 11
• butyl (E)-3-amino-2-cyano-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopent-2-enoate
• Tofacitinib Impurity TAB
• 1-Piperidinepropanenitrile, 3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
• Tofatib reference
• Tofacitinib Impurities1006
• Tofacitinib Impurities1007
• Tofacitinib Impurities1008
• Tofacitinib Impurities1009
• 3-[3-((6-Amino-pyrimidin-4-yl)-methyl-amino)-4-methyl-piperidin-1-yl]-3-oxo-propionitrile
• tofacitinib iMpurity
• Tofacitinib Impurity 21
• 3-((3R,4R)-3-((6-Aminopyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile (Tofacitinib Impurity）
• 1-Piperidinepropanenitrile, 3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
• Tofatinib Impurity 21
• (3R,4R)-3-[(6-Amino-4-pyrimidinyl)methylamino]-4-methyl-Beta-oxo-1-piperidinepropanenitrile
• 1640971-60-3
• ZJ
• ZY